These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 29145001)

  • 21. Hyaluronic acid coated poly(butyl cyanoacrylate) nanoparticles as anticancer drug carriers.
    He M; Zhao Z; Yin L; Tang C; Yin C
    Int J Pharm; 2009 May; 373(1-2):165-73. PubMed ID: 19429302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation and properties of hydroxycamptothecin-loaded nanoparticles made of amphiphilic copolymer and normal polymer.
    Wang J; Wang R; Li LB
    J Colloid Interface Sci; 2009 Aug; 336(2):808-13. PubMed ID: 19520376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sustained release of hydroxycamptothecin after subcutaneous administration using a novel phospholipid complex-DepoFoam technology.
    Zhao Y; Liu J; Sun X; Zhang ZR; Gong T
    Drug Dev Ind Pharm; 2010 Jul; 36(7):823-31. PubMed ID: 20515403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydroxycamptothecin nanoparticles based on poly/oligo (ethylene glycol): Architecture effects of nanocarriers on antitumor efficacy.
    Guo Y; Wang T; Qiu H; Han M; Dong Z; Wang X; Wang Y
    Eur J Pharm Biopharm; 2019 Jan; 134():178-184. PubMed ID: 30529294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation of a dispersible PEGylate nanostructured lipid carriers (NLC) loaded with 10-hydroxycamptothecin by spray-drying.
    Zhang X; Pan W; Gan L; Zhu C; Gan Y; Nie S
    Chem Pharm Bull (Tokyo); 2008 Dec; 56(12):1645-50. PubMed ID: 19043233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparison of bioavailability of two kinds of solid dispersion from 10-hydroxycamptothecin in SD rats in vivo].
    Wu XC; Hao HJ; Liu YX; Song XY; Zhang YZ; Zhang HQ
    Zhongguo Zhong Yao Za Zhi; 2016 Mar; 41(6):1130-1134. PubMed ID: 28875682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Poly(vinyl methyl ether/maleic anhydride)-Doped PEG-PLA Nanoparticles for Oral Paclitaxel Delivery To Improve Bioadhesive Efficiency.
    Wang Q; Li C; Ren T; Chen S; Ye X; Guo H; He H; Zhang Y; Yin T; Liang XJ; Tang X
    Mol Pharm; 2017 Oct; 14(10):3598-3608. PubMed ID: 28892400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms of chitosan-coated poly(lactic-co-glycolic acid) nanoparticles for improving oral absorption of 7-ethyl-10-hydroxycamptothecin.
    Guo M; Rong WT; Hou J; Wang DF; Lu Y; Wang Y; Yu SQ; Xu Q
    Nanotechnology; 2013 Jun; 24(24):245101. PubMed ID: 23702815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Preparation and characterization of hydroxycamptothecin nanoparticles of amphiphilic block copolymer].
    Xi N; Hou LB
    Zhong Yao Cai; 2009 Apr; 32(4):604-7. PubMed ID: 19645250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hydroxycamptothecin Nanorods Prepared by Fluorescently Labeled Oligoethylene Glycols (OEG) Codendrimer: Antitumor Efficacy in Vitro and in Vivo.
    Guo Y; Zhao Y; Wang T; Li R; Han M; Dong Z; Zhu C; Wang X
    Bioconjug Chem; 2017 Feb; 28(2):390-399. PubMed ID: 27982573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intracellular target delivery of 10-hydroxycamptothecin with solid lipid nanoparticles against multidrug resistance.
    Liu M; Chen D; Wang C; Chen X; Wen Z; Cao Y; He H
    J Drug Target; 2015; 23(9):800-5. PubMed ID: 25766079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cholesterol-PEG comodified poly (N-butyl) cyanoacrylate nanoparticles for brain delivery: in vitro and in vivo evaluations.
    Hu X; Yang F; Liao Y; Li L; Zhang L
    Drug Deliv; 2017 Nov; 24(1):121-132. PubMed ID: 28156159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carboplatin loaded Surface modified PLGA nanoparticles: Optimization, characterization, and in vivo brain targeting studies.
    Jose S; Juna BC; Cinu TA; Jyoti H; Aleykutty NA
    Colloids Surf B Biointerfaces; 2016 Jun; 142():307-314. PubMed ID: 26970818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Preparation of PEG-modified nanostructured lipid carriers loaded with hydroxycamptothecin and tissue distribution in mice].
    Zhang XX; Gan Y; Yang XG; Zhu CL; Gan L; Nie SF; Pan WS
    Yao Xue Xue Bao; 2008 Jan; 43(1):91-6. PubMed ID: 18357740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Miniemulsion polymerizations of n-butyl cyanoacrylate via two routes: towards a control of particle degradation.
    Hansali F; Poisson G; Wu M; Bendedouch D; Marie E
    Colloids Surf B Biointerfaces; 2011 Nov; 88(1):332-8. PubMed ID: 21802908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PEGylated nanostructured lipid carriers loaded with 10-hydroxycamptothecin: an efficient carrier with enhanced anti-tumour effects against lung cancer.
    Zhang X; Gan Y; Gan L; Nie S; Pan W
    J Pharm Pharmacol; 2008 Aug; 60(8):1077-87. PubMed ID: 18644200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipid nanoparticles loaded with 10-hydroxycamptothecin-phospholipid complex developed for the treatment of hepatoma in clinical application.
    Wei W; Shi SJ; Liu J; Sun X; Ren K; Zhao D; Zhang XN; Zhang ZR; Gong T
    J Drug Target; 2010 Aug; 18(7):557-66. PubMed ID: 20131981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A stabilizer-free and organic solvent-free method to prepare 10-hydroxycamptothecin nanocrystals: in vitro and in vivo evaluation.
    Yang X; Liu Y; Zhao Y; Han M; Guo Y; Kuang H; Wang X
    Int J Nanomedicine; 2016; 11():2979-94. PubMed ID: 27382284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stealth PEG-PHDCA niosomes: effects of chain length of PEG and particle size on niosomes surface properties, in vitro drug release, phagocytic uptake, in vivo pharmacokinetics and antitumor activity.
    Shi B; Fang C; Pei Y
    J Pharm Sci; 2006 Sep; 95(9):1873-87. PubMed ID: 16795003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, Preparation, and Evaluation of Osthol Poly-Butyl-Cyanoacrylate Nanoparticles with Improved In Vitro Anticancer Activity in Neuroblastoma Treatment.
    Zheng L; Shen L; Li Z; Zhang X; Wu M; Zhang Y; Liu J
    Molecules; 2022 Oct; 27(20):. PubMed ID: 36296500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.